OMEROS

Welcome to the Brand page for “OMEROS”, which is offered here for Pharmaceuticals, -- surgical compositions containing pharmacologic agents for the inhibition of pain, inflammation, cartilage loss, smooth muscle spasm and/or cell adhesion, for promoting mydriasis and/or for controlling intraocular pressure associated with surgical, diagnostic, therapeutic or medical procedures and other trauma; chondroprotective compositions containing pharmacologic agents for the treatment or inhibition of cartilage loss, pain and/or inflammation; pharmacologic agents and antibodies for the inhibition of the complement immune system; pharmacological agents for the treatment of schizophrenia and other psychiatric disorders; pharmacological agents for the treatment of parkinson's disease and other neuromuscular and neurodegenerative disorders; pharmacological agents for the treatment of obesity and other metabolic disorders; pharmacological agents for the treatment or inhibition of pain; pharmacological agents for the treatment of sleep and attention deficit disorders; and drug delivery systems, pharmacologic agents or antibodies carried in a hydrogel or micellular delivery vehicle;the english translation of the word omeros in the mark is homer.;.

Its status is currently believed to be active. Its class is unavailable. “OMEROS” is believed to be currently owned by “Omeros Corporation”.

Owner:
OMEROS CORPORATION
Owner Details
Description:
Pharmaceuticals, -- surgical compositions containing pharmacologic agents for the inhibition of pain, inflammation, cartilage loss, smooth muscle spasm and/or cell adhesion, for promoting mydriasis and/or for controlling intraocular pressure associated with surgical, diagnostic, therapeutic or medical procedures and other trauma; chondroprotective compositions containing pharmacologic agents for the treatment or inhibition of cartilage loss, pain and/or inflammation; pharmacologic agents and antibodies for the inhibition of the complement immune system; pharmacological agents for the treatment of schizophrenia and other psychiatric disorders; pharmacological agents for the treatment of Parkinson's disease and other neuromuscular and neurodegenerative disorders; pharmacological agents for the treatment of obesity and other metabolic disorders; pharmacological agents for the treatment or inhibition of pain; pharmacological agents for the treatment of sleep and attention deficit disorders; and drug delivery systems, pharmacologic agents or antibodies carried in a hydrogel or micellular delivery vehicle;The English translation of the word OMEROS in the mark is HOMER.;
Categories: PHARMACEUTICALS